InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by CARROLL J MARTIN, Director. Officer active across 3 companies, notably TherapeuticsMD, Inc.. In total, 7 filings have been recorded. Total volume traded: €26k. The latest transaction was disclosed on 2 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
€26,2115,000 shares@ €5.24220.0033% mcap100.0% of flow
Common Stock
SEC:0001628280-22-016165:0·
Ideal exit: 27 Feb 2023 (T+270)
03,136 shares0
Common Stock
SEC:0001596783-21-000194·
03,136 shares0
Common Stock
SEC:0001596783-21-000194:0·
01,402 shares0
Common Stock
SEC:0001596783-21-000169·
01,402 shares0
Common Stock
SEC:0001596783-21-000169:0·
96,864 shares
Common Stock
SEC:0001387131-21-008434·
96,864 shares
Common Stock
SEC:0001387131-21-008434:0·
7 of 7 declarations
About CARROLL J MARTIN
Martin J. Carroll is a Director at TherapeuticsMD, Inc., Catalent, Inc., and Esperion Therapeutics, Inc. As a board member, he participates in the governance and strategic decision-making for these companies. Martin brings his expertise to help guide their direction, ensuring compliance and performance. His role is essential for the sustainable development of these organizations.
